The BAP is a learned society and registered charity. It promotes research and education in psychopharmacology and related areas, and brings together people in academia, health services, and industry. Formed in 1974, it is the largest such national association in Europe, and the second largest in the world.
Summer Meeting 2018Join us in London 22nd to 25th July 2018
Antidepressants and SuicideProf Carmine Pariante attended House of Commons Health Select Committee regarding antidepressants and suicide
Metabolic Guidelines ArticleArticle on the recent metabolic guidelines by Peter Haddad, Gavin Reynolds and Stephen Cooper
Fundamentals Wins BMA AwardFundamentals of Clinical Psychopharmacology wins BMA Medical Book Award in Psychiatry
Fundamentals of Clinical PsychopharmacologyBuy a discounted copy of the new Fundamentals of Clinical Psychopharmacology
Online CPD ResourceRCPsych Online CPD Subscribers get a discount on the BAP Online Resource
New world order: Brexit, drugs and researchLetter to House of Commons Science and Technology Committee
The Ten Secrets of Success in ScienceView Professor Trevor Robbins presenting his top tips
Neuroscience-based Nomenclature (NbN) for JoPJournal of Psychopharmacology chosen to trial new NbN
Benefits of BAP membership include:
- FREE subscription and access to the Journal of Psychopharmacology (published monthly online).
- Reduced registration fees for the annual Summer Meeting.
- Half price subscription to the Online CPD Resource.
- Eligibility for prizes and awards.
- Student bursaries for the BAP Summer Meeting and international conferences.
- Reduced registration fees for selected partner association events.
- 50% OFF Royal Society of Biology membership (Read more)
- BAP Newsletter.
- Voting for BAP Officers and Council (full members only).
- Being part of one of the largest national psychopharmacology associations in the world.
|16th November 2017||Child and Adolescent Psychopharmacology||The County Hotel, Neville St, Newcastle upon Tyne|
|22nd November 2017||Day A: Schizophrenia / Substance Misuse||Hallam Conference Centre, 44 Hallam Street, London|
|23rd November 2017||Day B: Bipolar / Perinatal / ADHD||Hallam Conference Centre, 44 Hallam Street, London|
How functional neuroimaging is informing cognitive neurobiological models of auditory verbal hallucinations
By Thomas Dunne
Posted on 11th October 2017
Introduction Auditory verbal hallucinations (AVHs), or “hearing voices”, are a complex phenomenon characterised by abnormal perceptions of speech occurring in the absence of an appropriate external stimulus.1 Hallucinations of this modality hold great diagnostic significance, with Schneider’s (1959) first-rank symptoms of schizophrenia (including AVHs) still recognised today by major classification systems such as the International […]
Not just a four-letter word: The role of neuroendocrine factors in romantic love
By Thomas Dunne
Posted on 25th September 2017
Introduction In his poem ‘Love’s Trinity’, Victorian poet laureate Alfred Austin presents a holistic view of love, describing its impact on both our psyche and physiology:1,2 ‘Soul, heart, and body, we thus singly name, Are not in love divisible and distinct, But each with each inseparably link’d’ (A Austin).3 Romantic love has influenced literature and […]
SYMPOSIUM 2: The psychopharmacology of emerging calcium channel targets
By Nerissa Culi
Posted on 29th July 2017
Calcium ions (Ca2+) are universal intracellular messengers and, through selectively permeable calcium channels, can mediate and drive many important...
What can big data do for mental health treatment?
Claire features in this blog about big data and it's role in improving prescribing of depression treatment
15th August 2017
Is it safe to drink kava and drive?
Apo is interviewed by ABC News Australia on the effects of kava on driving
7th August 2017
Jeremy Hunt announces ‘major’ recruitment in mental health
Andrew has written an article for the Dorset Eye with his response to the Health Secretary's plans to recruit almost 10,000 staff to mental health posts over the next 4 years
2nd August 2017
A framework for a regulated market for cannabis in the UK: Recommendations from an expert panel
Professor Val Curran was interviewed by World at One on the release of the cannabis framework
12th May 2017
Predicting the effectiveness of antidepressants
Dr Claire Gillan is creating an internet-based tool which could predict how effective antidepressants will be for different individuals
11th May 2017
|Professor Trevor Robbins receives the 2017 Goldman-Rakic Award |
4th July 2017
We are pleased to announce that Professor Trevor Robbins has been elected to receive the 2017 Goldman-Rakic Award
|Bill Deakin to Receive 2017 BAP Lifetime Achievement Award |
14th June 2017
We are delighted to announce that the recipient of the 2017 BAP Lifetime Achievement Award is Professor Bill Deakin from Manchester.
|Perinatal Guidelines Meeting Now Open for Booking |
12th May 2017
Book your place on the Perinatal Guidelines Meeting
Book your place
|Perinatal Guidelines |
27th April 2017
The new Perinatal Guidelines are now online.
Most recent articles:
Journal of Psychopharmacology, Volume 31, Issue 10, Page 1281-1293, October 2017.
Journal of Psychopharmacology, Volume 31, Issue 10, Page 1294-1301, October 2017.
Journal of Psychopharmacology, Volume 31, Issue 10, Page 1302-1305, October 2017.
Psychopharmacology is the study of drugs that affect mood, behaviour and cognition. It aims to develop our understanding of the actions and effects of such drugs, which may include treatments for psychiatric disorders as well as substances that can be abused.